Haven't gotten to listen yet- was that Wheeler's phrasing? Because that would leave open the chance that sandoz/mnta are indeed planning either of the possibilities you mentioned- a bioequivlance trial or a trial targeting EU/ROW approvals
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.